Antimicrobial

  • AZITHROMYCIN 250MG

    A semi-synthetic macrolide antibiotic of the azalide class. Azithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.

  • AZITHROMYCIN 500MG

    A semi-synthetic macrolide antibiotic of the azalide class. Azithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.

  • CIPROFLOXACIN 500MG

    A broad-spectrum antimicrobial carboxyfluoroquinoline. The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, resulting in inhibition of DNA synthesis.

  • CLARITHROMYCIN 500MG

    Clarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit.

  • CLOTRIMAZOLE 100MG + METRONIDAZOLE 500MG + LACTOBACILLUS 31.250MG

    Clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity. It inhibits the fungal lanosterol 14-alpha-demethylase which thereby prevents the formation of ergosterol, an essential component in the fungal cell membrane, resulting in increased cellular permeability.
    Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.
    Lactobacillus acidophilus is a bacteria that exists naturally in the body, primarily in the digestive, urinary, and genital systems. Also called as �friendly bacteria�.

  • CLOTRIMAZOLE 100MG

    Clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity. It inhibits the fungal lanosterol 14-alpha-demethylase which thereby prevents the formation of ergosterol, an essential component in the fungal cell membrane, resulting in increased cellular permeability.

  • DILOXANIDE 500MG

    Diloxanide furoate is an anti-protozoal drug.

  • DOXYCYCLINE HYCLATE 100MG

    A synthetic tetracycline derivative with similar antimicrobial activity is used to inhibit bacterial protein synthesis.

  • FLUCONAZOLE 150MG

    Fluconazole, a synthetic antifungal agent of the imidazole class. It inhibits the fungal lanosterol 14-alpha-demethylase which thereby prevents the formation of ergosterol, an essential component in the fungal cell membrane, resulting in increased cellular permeability.

  • KETOCONAZOLE 200MG

    Broad spectrum antifungal agent. It inhibits the fungal lanosterol 14-alpha-demethylase which thereby prevents the formation of ergosterol, an essential component in the fungal cell membrane.

  • LEVOFLOXACIN 250MG

    A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

  • LEVOFLOXACIN 500MG

    A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

  • LINCOMYCIN 500MG

    A lincosamide antibiotic, which inhibits protein synthesis in susceptible bacteria by binding to the 50 S subunits of bacterial ribosomes and preventing peptide bond formation upon transcription.

  • METRONIDAZOLE 125MG/5ML

    Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.

  • METRONIDAZOLE BENZOATE 200MG/5ML

    Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.

  • METRONIDAZOLE 500MG + CLOTRIMAZOLE 100MG + LACTIC ACID BACILLUS PESSARIES 150 MILLION SPORES

    Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.
    Clotrimazole, an imidazole derivative with a broad spectrum of antimycotic activity. It inhibits the fungal lanosterol 14-alpha-demethylase which thereby prevents the formation of ergosterol, an essential component in the fungal cell membrane, resulting in increased cellular permeability.
    Lactobacillus acidophilus is a bacteria that exists naturally in the body, primarily in the digestive, urinary, and genital systems. Also called as �friendly bacteria�.

  • NALIDIXIC ACID 500MG

    Nalidixic acid is a quinolone antibacterial agent, binds strongly, but reversibly, to DNA, interfering with synthesis of RNA and, consequently, with protein synthesis.

  • NORFLOXACIN 100MG + METRONIDAZOLE100MG

    Norfloxacin is a synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity, blocks bacterial DNA replication by binding itself to an enzyme called DNA gyrase. Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death .

  • OFLOXACIN 200MG

    A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication

  • ORNIDAZOLE 500MG

    Ornidazole is a 5-nitroimidazole derivative active against protozoa and anaerobic bacteria. Interact with DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms.

  • ORNIDAZOLE 125MG/5ML

    Ornidazole is a 5-nitroimidazole derivative active against protozoa and anaerobic bacteria. Interact with DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms.

  • TRIMETHOPRIM 160MG + SULPHAMETHOXAZOLE 800MG

    Trimethoprim is a pyrimidine analogue that disrupts folate synthesis, by inhibiting dihydrofolate reductase. Inhibition of the enzyme starves the bacteria of nucleotides necessary for DNA replication. Sulfamethoxazole is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid.